BCLC Stage B Hepatocellular Carcinoma

subtype

Identifier: CI-CAN-00007281
Entity page: /cancer/bclc-stage-b-hepatocellular-carcinoma ↗
Edges: 27

Neighbours: 10 drugs10 trials
Drawn: 20 of 20 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
BCLC Stage B Hepatocellular Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived10 of 10
→ investigated in trials for	Pembrolizumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	BCLC Stage B Hepatocellular Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Atezolizumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants

BCLC Stage B Hepatocellular Carcinoma studied in …STUDIED_INderived10 of 17show all (up to 200)
→ studied in	NCT05199285Phase 2 · terminated A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active)	—	—	BCLC Stage B Hepatocellular Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04605731Phase 1 · active not recruiting Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active)	—	—	BCLC Stage B Hepatocellular Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07449637not yet recruiting Real-World Treatment Patterns and Survival Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma. · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active)	—	—	BCLC Stage B Hepatocellular Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04736121NA · active not recruiting Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma Patients · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active)	—	—	BCLC Stage B Hepatocellular Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07368530completed Using Machine Learning to Identify Responders to TACE or HAIC for uHCC · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active)	—	—	BCLC Stage B Hepatocellular Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04828486Phase 2 · completed Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active)	—	—	BCLC Stage B Hepatocellular Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02940496Phase 2 · completed Pembrolizumab (MK-3475) in Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active)	—	—	BCLC Stage B Hepatocellular Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05810402NA · recruiting Liver Cancer and Immunotherapy in the Liquid Biopsy Era · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active)	—	—	BCLC Stage B Hepatocellular Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05250895early Phase 1 · completed BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active)	—	—	BCLC Stage B Hepatocellular Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05776875Phase 2 · terminated Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC · condition mapped ONTOLOGY_EXACT · 17 trials mapped (5 active)	—	—	BCLC Stage B Hepatocellular Carcinoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains